Navigation Links
Malfunction of the respiratory epithelium is a cause of allergy?
Date:4/3/2009

One reason for the development of allergy may be malfunction of the respiratory epithelium, which allows allergens to bind to, enter and travel through the epithelium. Two studies by Finnish research groups on this subject have recently been published in two international biomedical journals (1) Allergy, and (2) Journal of Allergy and Clinical Immunology.

Research on the mechanisms of allergy has focused on the understanding of aberrant immunoresponses. Only lately the role of epithelium as the first line of defense against allergens has been realized. So far, we do not know why and how allergens are transported through the epithelium.

The research groups of the Helsinki University and Helsinki University Central Hospital in collaboration with several other Finnish research groups aimed to clarify what happens in the epithelium immediately after allergen exposure, before the allergic reaction develops. They used birch pollen allergen (Bet v 1) exposure and showed that this allergen binds to, enters and travels through conjunctival and nasal epithelium of allergic patients but not of healthy subjects within one minute after the exposure. An allergic reaction developed when the allergen reached mast cells under the basement membrane.

During the research it became evident that during spring, in allergic patients the birch pollen allergen Bet v 1 changed the expression of hundreds of genes of the nasal epithelium compared to samples taken during winter; and of these genes several were connected with protein transport and regulation of cytoskeleton. An astonishing finding was that the immune response of in healthy controls to pollen exposure was strong, and hundreds of genes changed their expression during winter and spring; however, many of these genes were related to the function of the immune response.

"We were able to describe a mechanism whereby birch pollen allergen Bet v 1 travels through the epithelium of allergic patients but not of healthy subjects. This kind of transport mechanisms are used by several viruses and bacteria when invading the epithelium and infecting patients", explains Professor Risto Renkonen (Haartman Institute, University of Helsinki and HUSLAB, Helsinki, Finland).

A systems biological approach was used in these studies, where data obtained concomitantly by several different methods is collected into a massive data warehouse allowing one to start analyzing the roles of different proteins and their networks in the pathogenesis of allergic reactions.

Reductionistic analyses, i.e., work focusing on one or only a few molecules are gradually replaced by systems approaches. The ability to discover new, etiologically relevant disease mechanisms is the major motivation for unbiased explorative approaches. The drawback of such top-down experiments is that they are very expensive and produce much more raw data than hypothesis-derived approaches thus generating an overflow of data. However, the urgent need to develop in silico data managing and analysis environments has been recognized by several research groups and biocompanies.


'/>"/>

Contact: Professor Risto Renkonen
risto.renkonen@helsinki.fi
358-405-535-219
University of Helsinki
Source:Eurekalert

Related biology news :

1. Iron-moving malfunction may underlie neurodegenerative diseases, aging
2. Prolonged respiratory problems for oil spill clean-up volunteers
3. Research leading to tools for managing bovine respiratory disease complex
4. Veterinary college researchers explore function of biofilm in bovine respiratory disease
5. deCODE discovers cause of major subtype of glaucoma
6. Study begins to reveal clues to the cause and progression of sepsis
7. Bleeding, not inflammation, is major cause of early lung infection death
8. Gamma globulin effective in treating eye infections caused by adenoviruses
9. Hidden interactions between predators and prey: evolution causes cryptic dynamics in ecology
10. Spaceflight shown to alter ability of bacteria to cause disease
11. Grubs passion for plastic causes water loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... 2017   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the latest ... highly flexible and award winning eClinical solution, is now ... is a proven Software-as-a-Service (SaaS) clinical research technology ... but also delivers an entire suite of eClinical tools ...
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
(Date:2/2/2017)... 2017  Central to its deep commitment to ... The Japan Prize Foundation today announced the laureates ... the envelope in their respective fields of Life ... are being recognized with the 2017 Japan Prize ... contribute to the advancement of science and technology, ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... ... February 22, 2017 , ... LabRoots , the leading ... around the world, is pleased to announce the launch of a new scholarship for ... (STEM) fields. , This merit-based scholarship is open to all high school seniors, 17 ...
(Date:2/22/2017)... -- Origin (Origin Agritech, LLC, a subsidiary of Origin Agritech Ltd.) ... Arcadia (Arcadia Biosciences, Inc., NASDAQ: RKDA), a ... traits and nutritional products, today announced their collaboration to achieve the ... China to the United States ... ...
(Date:2/22/2017)... ROCHELLE, VIRGINIA (PRWEB) , ... February 22, 2017 ... ... announced today that Dr. Daniel Spyker, PhD, MD former Acting Deputy Director in ... in CDER’s Pilot Drug Evaluation Staff has joined the company as an Expert ...
(Date:2/22/2017)... and SAN DIEGO ... Holdings (the "Company") (OTCQB:CELZ) announced today expansion of ... donor stem cell product through establishment of laboratory ... research activities at the San Diego BioLabs facility, ... Boehringer Ingelheim, Novartis, and Sanofi. In ...
Breaking Biology Technology: